GENZADA PHARMACEUTICALS Trademark

Trademark Overview


On Thursday, November 30, 2017, a trademark application was filed for GENZADA PHARMACEUTICALS with the United States Patent and Trademark Office. The USPTO has given the GENZADA PHARMACEUTICALS trademark a serial number of 87703407. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Monday, January 22, 2024. This trademark is owned by Genzada Pharmaceuticals USA, Inc.. The GENZADA PHARMACEUTICALS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceutical research and development; Scientific research and development
genzada pharmaceuticals

General Information


Serial Number87703407
Word MarkGENZADA PHARMACEUTICALS
Filing DateThursday, November 30, 2017
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateMonday, January 22, 2024
Registration Number5523316
Registration DateTuesday, July 24, 2018
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, May 8, 2018

Trademark Statements


Description of MarkThe mark consists of the stacked words "GENZADA" and "PHARMACEUTICALS", to the right of and partially underneath the stylized image of a tree.
Indication of Colors claimedColor is not claimed as a feature of the mark.
Disclaimer with Predetermined Text"PHARMACEUTICALS"
Goods and ServicesPharmaceutical research and development; Scientific research and development

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, December 11, 2017
Primary Code042
First Use Anywhere DateThursday, April 30, 2015
First Use In Commerce DateThursday, April 30, 2015

Trademark Owner History


Party NameANKH LIFE SCIENCES LIMITED
Party Type30 - Original Registrant
Legal Entity Type77 - NOT AVAILABLE
AddressDUBLIN 2 D02DK18
IE

Party NameANKH LIFE SCIENCES LIMITED
Party Type21 - New Owner After Publication
Legal Entity Type77 - NOT AVAILABLE
AddressDUBLIN 2 D02DK18
IE

Party NameGenzada Pharmaceuticals USA, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSterling, KS 67579

Party NameGenzada Pharmaceuticals USA, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSterling, KS 67579

Trademark Events


Event DateEvent Description
Monday, January 22, 2024NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Monday, January 22, 2024REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Monday, January 22, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, July 27, 2023TEAS SECTION 8 & 15 RECEIVED
Monday, July 24, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, July 24, 2018REGISTERED-PRINCIPAL REGISTER
Wednesday, June 13, 2018AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, May 8, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 8, 2018PUBLISHED FOR OPPOSITION
Wednesday, April 18, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, March 30, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, March 19, 2018EXAMINER'S AMENDMENT ENTERED
Sunday, March 18, 2018ASSIGNED TO LIE
Sunday, March 18, 2018NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Sunday, March 18, 2018EXAMINERS AMENDMENT E-MAILED
Sunday, March 18, 2018EXAMINERS AMENDMENT -WRITTEN
Saturday, March 17, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, March 17, 2018NON-FINAL ACTION E-MAILED
Saturday, March 17, 2018NON-FINAL ACTION WRITTEN
Tuesday, March 13, 2018ASSIGNED TO EXAMINER
Tuesday, December 12, 2017NOTICE OF DESIGN SEARCH CODE E-MAILED
Monday, December 11, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, December 4, 2017NEW APPLICATION ENTERED